Overview

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of the veliparib/TMZ combination in subjects with solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott
Treatments:
Dacarbazine
Temozolomide
Veliparib